![Per Richard Torbjörn Hallberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 4 Mio $ am 31.05.2026
Per Richard Torbjörn Hallberg is currently a Director at Takeda Oy, Dova Pharmaceuticals, Inc., Swedish Orphan Biovitrum, Inc., Swedish Orphan Biovitrum (Belgium) SARL, and General Counsel & Head-Legal Affairs at Swedish Orphan Biovitrum AB. Previously, he worked as a Senior Associate at Advokatfirman Lindahl KB, Corporate Counsel at Ferring Pharmaceuticals, Inc., Corporate Counsel at Nycomed AB, and Vice President & General Counsel-Emerging Markets at Takeda AB. He obtained a graduate degree from the University of Lund.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 78’949 ( 0.02% ) | 4 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | 01.01.2018 |
| DOVA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 12.11.2019 |
Takeda Oy
 Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 01.05.2016 |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Direktor/Vorstandsmitglied | - |
Swedish Orphan Biovitrum (Belgium) SARL
 Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Direktor/Vorstandsmitglied | 01.06.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Takeda AB | Direktor/Vorstandsmitglied | 01.01.2017 |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | General Counsel | 01.01.2010 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | General Counsel | 01.01.2004 |
Advokatfirman Lindahl KB
 Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.01.2001 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Takeda AB | |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
